Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Aldeyra Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 120 | 105 | −15 |
| Shares | 37.8M | 35.1M | −2.65M (−7.0%) |
| Value | $252.3M | $123.3M | −$129.0M (−51.1%) |
New holders (21)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 1,276,146 | $4.48M | 0.10% |
| Acadian Asset Management LLC | 219,280 | $768.0K | 0.00% |
| Los Angeles Capital Management LLC | 111,712 | $392.1K | 0.00% |
| Squarepoint Ops LLC | 72,964 | $256.1K | 0.00% |
| Cornercap Investment Counsel Inc | 61,601 | $216.2K | 0.04% |
| Engineers Gate Manager LP | 57,146 | $200.6K | 0.01% |
| HRT Financial LP | 44,826 | $157.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 25,354 | $89.0K | 0.01% |
| LPL Financial LLC | 18,822 | $66.1K | 0.00% |
| Qube Research & Technologies Ltd | 15,629 | $54.9K | 0.00% |
| Two Sigma Securities, LLC | 15,294 | $53.7K | 0.00% |
| XTX Topco Ltd | 11,991 | $42.1K | 0.01% |
| NorthRock Partners, LLC | 11,951 | $41.9K | 0.00% |
| SG Americas Securities, LLC | 11,028 | $39.0K | 0.00% |
| Prime Capital Investment Advisors, LLC | 10,088 | $35.4K | 0.00% |
| Washington Trust Advisors, Inc. | 3,800 | $13.3K | 0.00% |
| Farther Finance Advisors, LLC | 3,005 | $10.5K | 0.00% |
| Advisory Services Network, LLC | 500 | $1.75K | 0.00% |
| CWM, LLC | 191 | $1.00K | 0.00% |
| Nisa Investment Advisors, LLC | 40 | $140 | 0.00% |
| Providence Wealth Advisors, LLC | 1,340 | – | – |
Sold out (36)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.